Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency

Clinical Endocrinology

Volumn 76, Issue 1, 2012, Pages 88-95

  Roemmler, J ^a   Gockel, A ^a   Otto, B ^a   Bidlingmaier, M ^a   Schopohl, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; GHRELIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LB 03002; LEPTIN; LOW DENSITY LIPOPROTEIN; PLACEBO; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GROWTH HORMONE DEFICIENCY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUSTAINED RELEASE FORMULATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADULT; AGED; BLOOD GLUCOSE; BODY COMPOSITION; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GHRELIN; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; MIDDLE AGED;

EID: 83455200245     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04146.x     Document Type: Article

References (49)

1. Bidlingmaier, M., Kim, J., Savoy, C., et al. (2006) Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 91, 2926-2930. (Pubitemid 44271737)
2. Alford, F.P., Hew, F.L., Christopher, M.C., et al. (1999) Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy. Journal of Endocrinological Investigation 22, 28-32.
3. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
4. Giavoli, C., Porretti, S., Ronchi, C.L., et al. (2004) Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy. Metabolism 53, 740-743. (Pubitemid 38880904)
5. Spina, L.D., Soares, D.V., Brasil, R.R., et al. (2004) Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement. Pituitary 7, 123-129. (Pubitemid 43336599)
6. Bulow, B., Hagmar, L., Mikoczy, Z., et al. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology (Oxford) 46, 75-81. (Pubitemid 27072849)
7. Rosen, T., &, Bengtsson, B.A., (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285-288. (Pubitemid 20229130)
8. Joaquin, C., Aguilera, E., Granada, M.L., et al. (2008) Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A. European Journal of Endocrinology 158, 483-490. (Pubitemid 351606343)
9. Miyakawa, M., Tsushima, T., Murakami, H., et al. (1998) Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency. Journal of Clinical Endocrinology and Metabolism 83, 3476-3479. (Pubitemid 28500874)
10. Malik, I.A., English, P.J., Ghatei, M.A., et al. (2004) The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clinical Endocrinology (Oxford) 60, 137-141. (Pubitemid 38183509)
11. Rizza, R.A., Mandarino, L.J., &, Gerich, J.E., (1982) Effects of growth hormone on insulin action in man Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31, 663-669. (Pubitemid 12095161)
12. Cenci, M.C., Conceicao, F.L., Soares, D.V., et al. (2008) Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults. Metabolism 57, 121-129. (Pubitemid 350245387)
13. Svensson, J., Fowelin, J., Landin, K., et al. (2002) Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 87, 2121-2127. (Pubitemid 34525079)
14. Attanasio, A.F., Bates, P.C., Ho, K.K., et al. (2002) Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS Database. Journal of Clinical Endocrinology and Metabolism 87, 1600-1606. (Pubitemid 34618501)
15. van der Klaauw, A.A., Romijn, J.A., Biermasz, N.R., et al. (2006) Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency. European Journal of Endocrinology 155, 701-708. (Pubitemid 44857494)
16. Chrisoulidou, A., Beshyah, S.A., Rutherford, O., et al. (2000) Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 85, 3762-3769.
17. Gotherstrom, G., Elbornsson, M., Stibrant-Sunnerhagen, K., et al. (2009) Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 94, 809-816.
18. Clanget, C., Seck, T., Hinke, V., et al. (2001) Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults. Clinical Endocrinology (Oxford) 55, 93-99. (Pubitemid 34204304)
19. Gotherstrom, G., Bengtsson, B.A., Bosaeus, I., et al. (2007) Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. European Journal of Endocrinology 156, 55-64. (Pubitemid 46561839)
20. Roemmler, J., Kuenkler, M., Otto, B., et al. (2009) Influence of long-term growth hormone replacement on leptin and ghrelin in GH deficiency before and after glucose load. Regulatory Peptides 158, 40-46.
21. Fisker, S., Vahl, N., Hansen, T.B., et al. (1997) Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year. Metabolism 46, 812-817. (Pubitemid 27300626)
22. Janssen, J.A., van der Toorn, F.M., Hofland, L.J., et al. (2001) Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. European Journal of Endocrinology 145, 711-716. (Pubitemid 33133677)
23. Cook, D.M., Biller, B.M., Vance, M.L., et al. (2002) The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 87, 4508-4514. (Pubitemid 35251858)
24. Hoffman, A.R., Biller, B.M., Cook, D., et al. (2005) Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 90, 6431-6440. (Pubitemid 41759296)
25. Biller, B.M., Ji, H.J., Ahn, H., et al. (2011) Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 96, 1718-1726.
26. Bristow, A.F., Gooding, R.P., &, Das, R.E., (1990) The International Reference Reagent for insulin-like growth factor-I. Journal of Endocrinology 125, 191-197. (Pubitemid 20146333)
27. Elmlinger, M.W., Kuhnel, W., Weber, M.M., et al. (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clinical Chemistry and Laboratory Medicine 42, 654-664. (Pubitemid 38979144)
28. Wu, Z., Bidlingmaier, M., Liu, C., et al. (2002) Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. Journal of Clinical Endocrinology and Metabolism 87, 2931-2939. (Pubitemid 34655366)
29. Matsuda, M., &, DeFronzo, R.A., (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470. (Pubitemid 29418240)
30. Hwu, C.M., Kwok, C.F., Lai, T.Y., et al. (1997) Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. Journal of Clinical Endocrinology and Metabolism 82, 3285-3292. (Pubitemid 27419073)
31. Bramnert, M., Segerlantz, M., Laurila, E., et al. (2003) Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. Journal of Clinical Endocrinology and Metabolism 88, 1455-1463. (Pubitemid 36623354)
32. Eden Engstrom, B., Burman, P., Holdstock, C., et al. (2003) Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 88, 5193-5198. (Pubitemid 37455410)
33. Roemmler, J., Kuenkler, M., Schneider, H.J., et al. (2010) Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement. Metabolism 59, 350-358.
34. Attallah, H., Friedlander, A.L., &, Hoffman, A.R., (2006) Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy. Growth Hormone & IGF Research 16 (Suppl A), S62-S67.
35. Sangiao-Alvarellos, S., &, Cordido, F., (2010) Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications. International Journal Of Peptides 2010, [Epub ahead].
36. Hamann, A., &, Matthaei, S., (1996) Regulation of energy balance by leptin. Experimental and Clinical Endocrinology and Diabetes 104, 293-300. (Pubitemid 26306120)
37. Shiiya, T., Nakazato, M., Mizuta, M., et al. (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism 87, 240-244. (Pubitemid 34084697)
38. Tschop, M., Weyer, C., Tataranni, P.A., et al. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707-709. (Pubitemid 32242624)
39. Broglio, F., Gottero, C., Prodam, F., et al. (2004) Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans. Clinical Endocrinology (Oxford) 61, 503-509. (Pubitemid 39388490)
40. Ketel, I.J., Volman, M.N., Seidell, J.C., et al. (2007) Superiority of skinfold measurements and waist over waist-to-hip ratio for determination of body fat distribution in a population-based cohort of Caucasian Dutch adults. European Journal of Endocrinology 156, 655-661. (Pubitemid 46952535)
41. Goodman-Gruen, D., &, Barrett-Connor, E., (1996) Sex differences in measures of body fat and body distribution in the elderly. American Journal of Epidemiology 143, 898-906. (Pubitemid 26131097)
42. Schneider, H.J., Friedrich, N., Klotsche, J., et al. (2010) The predictive value of different measures of obesity for incident cardiovascular events and mortality. Journal of Clinical Endocrinology and Metabolism 95, 1777-1785.
43. Abs, R., Feldt-Rasmussen, U., Mattsson, A.F., et al. (2006) Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults-a KIMS database analysis. European Journal of Endocrinology 155, 79-90. (Pubitemid 44109069)
44. Murray, R.D., Adams, J.E., &, Shalet, S.M., (2006) A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 91, 432-438. (Pubitemid 43236906)
45. Hansen, T.B., Brixen, K., Vahl, N., et al. (1996) Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 81, 3352-3359. (Pubitemid 26296215)
46. Johannsson, G., Rosen, T., Bosaeus, I., et al. (1996) Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 81, 2865-2873. (Pubitemid 26323877)
47. Gomez-Ambrosi, J., Rodriguez, A., Catalan, V., et al. (2008) The bone-adipose axis in obesity and weight loss. Obesity Surgery 18, 1134-1143.
48. Giannoulis, M.G., Jackson, N., Shojaee-Moradie, F., et al. (2006) Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial. Growth Hormone & IGF Research 16, 308-317. (Pubitemid 44793714)
49. Giannoulis, M.G., Sonksen, P.H., Umpleby, M., et al. (2006) The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 91, 477-484. (Pubitemid 43236912)